Efficacy of Karpanpatru Taila Roll on, prepared with sesame oil and coconut oil on Vitiligo

Pharmaceutical standardization of Karpanapatru Taila Roll-on prepared with Tila Taila and Narikela Taila and their comparative efficacy in the management of Shvitra (Vitiligo) - KPT

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/03/006759

Enrollment

Registered

2016-03-22

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue Health Condition 2: null- Shvitra (Vitiligo)

Interventions

Intervention1: Karpanpatru taila Roll on prepared from tila taila: external medicament in sufficient quantity for 2 months Control Intervention1: Karpanpatru taila Roll on prepared with Narikela tail

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of Shvitra (vitiligo). Patients having Sadhya Lakshana of Shvitra. Patients having ages of 16 to 60 years. Patients with chronicity of less than 10 years. Woodâ??s lamp test positive.

Exclusion criteria

Exclusion criteria: Age 60 years Chronicity more than 10 years. Serious cardiac, renal, hepatic diseases, major illness like IDDM, NIDDM, patches due to burning, chemical, any other serious systemic illness. Gravid and lactating women. Ekanga (Segmental Vitiligo) Patches with Raktaroma (reddish hair) & Samsakta (coalescent). Hypersensitive and Photosensitive patients

Design outcomes

Primary

Measure	Time frame
Test drug will be effective in reducing patches of vitiligoTimepoint: 8 weeks	—

Secondary

Measure	Time frame
It will improve quality of life and complexion of bodyTimepoint: 8 weeks	—

Countries

India

Contacts

Public ContactPrashant bedarkar

Institute for Post Graduate teaching and Research in Ayurveda

drprashantbedarkar@gmail.com8128217370

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026